In addition to direct-to-physician pharmaceutical marketing activities, her research interests include the valuation of firms’ intangible marketing assets. For further detail on this research, see “Are Physicians ‘Easy Marks’? Quantifying the Effects of Detailing and Sampling on New Prescriptions” (from the December 2004 issue of Management Science) by visiting Columbia Ideas at Work. 